Eton Pharmaceuticals, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2023 Annual Meeting of Stockholders held on June 13, 2023, in Deer Park, Illinois. Eton Pharmaceuticals, Inc. is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1: Election of Directors
- Jenn Adams: Elected with 11,008,471 votes For, 393,816 Against, and 3,567 Abstentions. There were 6,787,111 Broker Non-Votes.
- Charles J. Casamento: Elected with 10,808,753 votes For, 594,949 Against, and 2,152 Abstentions. There were 6,787,111 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditor
- KMJ Corbin & Company LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2023.
- Votes: 18,092,275 For, 63,090 Against, and 37,600 Abstentions. There were 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation of the three-year term for newly elected directors Jenn Adams and Charles J. Casamento.
- Verification of KMJ Corbin & Company LLP's engagement as the independent auditor for fiscal year 2023.
- Review of the significant number of broker non-votes (6,787,111) recorded for the director elections.